Pancreatic Cancer Research

ResearcherThe University of Texas MD Anderson Cancer CenterNo recent work listed

Or P. Gozani

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0002-1365-4463; OpenAlex author ID A5069105266; NIH RePORTER profile ID 1907892. Sources: OpenAlex.

Their work

Papers
2
Trials
0
Grants
2
Labs led
1
Collaborators
8
Papers, trials and grants by year

2016: 1 paper · 2017: none · 2018: none · 2019: none · 2020: 1 paper · 2021: none · 2022: none · 2023: 2 grants

Papers 2

  1. SETD5-Coordinated Chromatin Reprogramming Regulates Adaptive Resistance to Targeted Pancreatic Cancer Therapy. Co-author DOI 10.1016/j.ccell.2020.04.014↗
  2. Coordination of stress signals by the lysine methyltransferase SMYD2 promotes pancreatic cancer. Co-author DOI 10.1101/gad.275529.115↗

Grants 2

  1. Role of the METTL13 Lysine Methyltransferase in Signaling and Cancer R01CA236118↗
  2. Role of SETD5 in Chromatin Regulation and Tumorigenesis R01CA236949↗

Closest collaborators

The 8 strongest of 8 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Pawel Karol Mazur · 2 shared papers, 2 shared grants, 2016–2023 · strength 1.68
  2. Julien Sage · 2 shared papers, 2016–2020 · strength 0.13
  3. Huamin Wang · 1 shared paper, 2020 · strength 0.08
  4. Michael P. Kim · 1 shared paper, 2020 · strength 0.08
  5. Anirban Maitra · 1 shared paper, 2020 · strength 0.08
  6. Zhentian Wang · 1 shared paper, 2020 · strength 0.08
  7. Simone Hausmann · 1 shared paper, 2020 · strength 0.08
  8. Nicolas Reynoird · 1 shared paper, 2016 · strength 0.05

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.